220 related articles for article (PubMed ID: 1982811)
1. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
[TBL] [Abstract][Full Text] [Related]
2. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
Bald M; Bonzel KE; Rascher W
Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
[TBL] [Abstract][Full Text] [Related]
4. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
Rascher W; Bald M; Kröner F; Tulassay T; Müller-Wiefel DE
Z Kardiol; 1988; 77 Suppl 2():61-4. PubMed ID: 2970176
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans.
Fincher ME; Campbell HT; Sklar AH; Caruana RJ; Lightfoot BO; Cheek PL; Smith KL; Hess CP
Adv Perit Dial; 1989; 5():16-9. PubMed ID: 2577402
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
Korzets Z; Pomeranz M; Shilo L; Pomeranze A; Levi A; Shenkman L; Berheim J
Adv Perit Dial; 1989; 5():20-3. PubMed ID: 2577411
[TBL] [Abstract][Full Text] [Related]
8. [Levels of immunoreactive atrial natriuretic peptide in the blood of children on hemodialysis therapy].
Jovanović O; Mirić-Nastić D; Popović-Rolović M; Antić-Peco A; Kostić M; Kruscić D
Srp Arh Celok Lek; 1992; 120(9-10):277-80. PubMed ID: 1306019
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
Kohse KP; Feifel K; Mayer-Wehrstein R
Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
11. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
Ando R; Matsuda O; Miyake S; Yoshiyama N
Nephron; 1988; 50(3):225-8. PubMed ID: 2976122
[TBL] [Abstract][Full Text] [Related]
13. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
14. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
[TBL] [Abstract][Full Text] [Related]
15. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
[TBL] [Abstract][Full Text] [Related]
16. Plasma human brain natriuretic peptide in chronic renal failure.
Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
[TBL] [Abstract][Full Text] [Related]
17. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
[TBL] [Abstract][Full Text] [Related]
18. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
19. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
Jespersen B; Pedersen EB
Nephrol Dial Transplant; 1988; 3(6):762-7. PubMed ID: 2976128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
